Improving Medication Adherence in Inflammatory Bowel Disease
Author Information
Author(s): Feig Vivian Rachel, Zhang Sufeng, Patel Ashka, Santos Bruna, Kang Ziliang, Wasan Sharmeel, Beloqui Ana, Traverso Giovanni
Primary Institution: Brigham and Women's Hospital, Harvard Medical School
Hypothesis
What are the main barriers to medication adherence in inflammatory bowel disease and how can they be addressed?
Conclusion
The study identifies key barriers to medication adherence in inflammatory bowel disease and suggests multidisciplinary approaches to improve self-administration of biotherapeutics.
Supporting Evidence
- Self-administration of biotherapeutics can improve patient preference and reduce healthcare costs.
- Barriers to adherence include the route and frequency of administration and side effects.
- Technological innovations can help address these barriers and improve medication adherence.
Takeaway
This study looks at why people with inflammatory bowel disease sometimes forget to take their medicine and suggests ways to help them remember.
Methodology
The review analyzes existing literature on medication adherence in inflammatory bowel disease and identifies barriers and potential solutions.
Potential Biases
Self-reported adherence data may be subject to bias.
Limitations
The review relies on existing studies, which may have varying methodologies and participant demographics.
Participant Demographics
The studies reviewed primarily focus on adult patients with inflammatory bowel disease, with a mean age around 40, predominantly from Western countries.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website